Skip to main content
SpringerLink
Log in
Book cover

Adult Acute Lymphocytic Leukemia pp 1–7Cite as

A Perspective on the Treatment of Acute Lymphoblastic Leukemia in Adults

  • Chapter
  • First Online:

  • 1483 Accesses

Part of the book series: Contemporary Hematology ((CH))

Abstract

The progressive improvement in the outcome of children treated for acute lymphoblastic leukemia (ALL) represents one of the major achievements of clinical cancer research and is frequently singled out as an example of the progress to be hoped for in other cancers.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Pui, C. H., Robison, L. L., & Look, A. T. (2008). Acute lymphoblastic leukaemia. Lancet, 371, 1030–1043.

    Article  PubMed  CAS  Google Scholar 

  2. Hoelzer, D., Gokbuget, N., Digel, W., et al. (2002). Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood, 99, 4379–4385.

    Article  PubMed  CAS  Google Scholar 

  3. Hoelzer, D., Thiel, E., Loffler, H., et al. (1984). Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood, 64, 38–47.

    PubMed  CAS  Google Scholar 

  4. Larson, R. A., Dodge, R. K., Burns, C. P., et al. (1995). A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8811. Blood, 85, 2025–2037.

    PubMed  CAS  Google Scholar 

  5. Ellison, R. R., Mick, R., Cuttner, J., et al. (1991). The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: A prospective randomized clinical trial by Cancer and Leukemia Group B. Journal of Clinical Oncology, 9, 2002–2015.

    PubMed  CAS  Google Scholar 

  6. Goldstone, A. H., Richards, S. M., Lazarus, H. M., et al. (2008). In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: Final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood, 111, 1827–1833.

    Article  PubMed  CAS  Google Scholar 

  7. Rowe, J. M., Buck, G., Burnett, A. K., et al. (2005). Induction therapy for adults with acute lymphoblastic leukemia: Results of more than 1500 patients from the International ALL trial: MRC UKALL XII/ECOG E2993. Blood, 106, 3760–3767.

    Article  PubMed  CAS  Google Scholar 

  8. Pullarkat, V., Slovak, M. L., Kopecky, K. J., Forman, S. J., & Appelbaum, F. R. (2008). Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: Results of Southwest Oncology Group 9400 study. Blood, 111, 2563–2572.

    Article  PubMed  CAS  Google Scholar 

  9. Wetzler, M., Dodge, R. K., Mrozek, K., et al. (1999). Prospective karyotype analysis in adult acute lymphoblastic leukemia: The cancer and leukemia Group B experience. Blood, 93, 3983–3993.

    PubMed  CAS  Google Scholar 

  10. Pui, C. H. (2005). Impact of molecular profiling and cytogenetics in acute lymphoblastic leukemia. Hematology, 10(Suppl 1), 176–177.

    Article  PubMed  Google Scholar 

  11. Raimondi, S. C., Behm, F. G., Roberson, P. K., et al. (1988). Cytogenetics of childhood T-cell leukemia. Blood, 72, 1560–1566.

    PubMed  CAS  Google Scholar 

  12. Raimondi, S. C., Behm, F. G., Roberson, P. K., et al. (1990). Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1, 19). Journal of Clinical Oncology, 8, 1380–1388.

    PubMed  CAS  Google Scholar 

  13. Greaves, M. (1993). A natural history for pediatric acute leukemia. Blood, 82, 1043–1051.

    PubMed  CAS  Google Scholar 

  14. Greaves, M. F., Maia, A. T., Wiemels, J. L., & Ford, A. M. (2003). Leukemia in twins: Lessons in natural history. Blood, 102, 2321–2333.

    Article  PubMed  CAS  Google Scholar 

  15. Taub, J. W., Konrad, M. A., Ge, Y., et al. (2002). High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood, 99, 2992–2996.

    Article  PubMed  CAS  Google Scholar 

  16. Taub, J. W., Mundschau, G., Ge, Y., et al. (2004). Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome. Blood, 104, 1588–1589.

    Article  PubMed  CAS  Google Scholar 

  17. Cunningham, L., & Aplenc, R. (2007). Pharmacogenetics of acute lymphoblastic leukemia treatment response. Expert Opinion on Pharmacotherapy, 8, 2519–2531.

    Article  PubMed  CAS  Google Scholar 

  18. Lee, E. J., Petroni, G. R., Schiffer, C. A., et al. (2001). Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: Results of cancer and leukemia group B study 9251. Journal of Clinical Oncology, 19, 4014–4022.

    PubMed  CAS  Google Scholar 

  19. Thomas, D. A., Cortes, J., O’Brien, S., et al. (1999). Hyper-CVAD program in Burkitt’s-type adult acute lymphoblastic leukemia. Journal of Clinical Oncology, 17, 2461–2470.

    PubMed  CAS  Google Scholar 

  20. Thomas, D. A., Faderl, S., O’Brien, S., et al. (2006). Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer, 106, 1569–1580.

    Article  PubMed  CAS  Google Scholar 

  21. de Labarthe, A., Rousselot, P., Huguet-Rigal, F., et al. (2007). Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: Results of the GRAAPH-2003 study. Blood, 109, 1408–1413.

    Article  PubMed  Google Scholar 

  22. Ottmann, O., Dombret, H., Martinelli, G., et al. (2007). Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: Interim results of a phase 2 study. Blood, 110, 2309–2315.

    Article  PubMed  CAS  Google Scholar 

  23. Wassmann, B., Pfeifer, H., Goekbuget, N., et al. (2006). Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL). Blood, 108, 1469–1477.

    Article  PubMed  CAS  Google Scholar 

  24. Boissel, N., Auclerc, M. F., Lheritier, V., et al. (2003). Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. Journal of Clinical Oncology, 21, 774–780.

    Article  PubMed  Google Scholar 

  25. de Bont, J. M., Holt, B., Dekker, A. W., van der Does-van den Berg, A., Sonneveld, P., & Pieters, R. (2004). Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia, 18, 2032–2035.

    Article  PubMed  Google Scholar 

  26. Hallbook, H., Gustafsson, G., Smedmyr, B., Soderhall, S., & Heyman, M. (2006). Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: A comparison between a pediatric protocol and an adult protocol. Cancer, 107, 1551–1561.

    Article  PubMed  Google Scholar 

  27. Ramanujachar, R., Richards, S., Hann, I., & Webb, D. (2006). Adolescents with acute lymphoblastic leukaemia: Emerging from the shadow of paediatric and adult treatment protocols. Pediatric Blood & Cancer, 47, 748–756.

    Article  Google Scholar 

  28. Stock, W., La, M., Sanford, B., et al. (2008). What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children’s Cancer Group and Cancer and Leukemia Group B studies. Blood, 112, 1646–1654.

    Article  PubMed  CAS  Google Scholar 

  29. Ribera, J. M., Oriol, A., Sanz, M. A., et al. (2008). Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en Hematologia pediatric-based protocol ALL-96. Journal of Clinical Oncology, 26, 1843–1849.

    Article  PubMed  CAS  Google Scholar 

  30. Barry, E., DeAngelo, D. J., Neuberg, D., et al. (2007). Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. Journal of Clinical Oncology, 25, 813–819.

    Article  PubMed  CAS  Google Scholar 

  31. Borowitz, M. J., Devidas, M., Hunger, S. P., et al. (2008). Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children’s Oncology Group study. Blood, 111, 5477–5485.

    Article  PubMed  CAS  Google Scholar 

  32. Fiere, D., Lepage, E., Sebban, C., et al. (1993). Adult acute lymphoblastic leukemia: A multicentric randomized trial testing bone marrow transplantation as postremission therapy The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 11, 1990–2001.

    PubMed  CAS  Google Scholar 

  33. Cornelissen, J. J., van der Holt, B., Verhoef, G. E., et al. (2009). Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: A prospective sibling donor versus no-donor comparison. Blood, 113, 1375–1382.

    Article  PubMed  CAS  Google Scholar 

  34. DeAngelo, D. J., Yu, D., Johnson, J. L., et al. (2007). Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. Blood, 109, 5136–5142.

    Article  PubMed  CAS  Google Scholar 

  35. Kurtzberg, J. (2007). The long and winding road of the clinical development of Nelarabine. Leukaemia & Lymphoma, 48, 1–2.

    Article  CAS  Google Scholar 

  36. Armstrong, F., de la Grange, P. B., Gerby, B., et al. (2009). NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity. Blood, 113, 1730–1740.

    Article  PubMed  CAS  Google Scholar 

  37. Grabher, C., von Boehmer, H., & Look, A. T. (2006). Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nature Reviews Cancer, 6, 347–359.

    Article  PubMed  CAS  Google Scholar 

  38. Grosveld, G. C. (2009). Gamma-secretase inhibitors: Notch so bad. Natural Medicines, 15, 20–21.

    Article  CAS  Google Scholar 

  39. Leonetti, C., Scarsella, M., Semple, S. C., et al. (2004). In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors. International Journal of Cancer, 110, 767–774.

    Article  CAS  Google Scholar 

  40. Stanciu-Herrera, C., Morgan, C., & Herrera, L. (2008). Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines. Leukemia Research, 32, 625–632.

    Article  PubMed  CAS  Google Scholar 

  41. Raetz, E. A., Cairo, M. S., Borowitz, M. J., et al. (2008). Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: A Children’s Oncology Group Pilot Study. Journal of Clinical Oncology, 26, 3756–3762.

    Article  PubMed  CAS  Google Scholar 

  42. Thomas, D. A., O’Brien, S., Jorgensen, J. L., et al. (2009). Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia. Blood, 113(25), 6330–6337.

    Article  PubMed  CAS  Google Scholar 

  43. Cox, C. V., Martin, H. M., Kearns, P. R., Virgo, P., Evely, R. S., & Blair, A. (2007). Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood, 109, 674–682.

    Article  PubMed  CAS  Google Scholar 

  44. Mullighan, C. G., Su, X., Zhang, J., et al. (2009). Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. The New England Journal of Medicine, 360, 470–480.

    Article  PubMed  CAS  Google Scholar 

  45. Kuiper, R. P., Schoenmakers, E. F., van Reijmersdal, S. V., et al. (2007). High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia, 21, 1258–1266.

    Article  PubMed  CAS  Google Scholar 

  46. Mullighan, C. G., Goorha, S., Radtke, I., et al. (2007). Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature, 446, 758–764.

    Article  PubMed  CAS  Google Scholar 

  47. Fearon, E. R., Burke, P. J., Schiffer, C. A., Zehnbauer, B. A., & Vogelstein, B. (1986). Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. The New England Journal of Medicine, 315, 15–24.

    Article  PubMed  CAS  Google Scholar 

  48. Molldrem, J. J., Lee, P. P., Wang, C., et al. (2000). Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Natural Medicines, 6, 1018–1023.

    Article  CAS  Google Scholar 

  49. Molldrem, J. J. (2006). Vaccination for leukemia. Biology of Blood and Marrow Transplantation, 12, 13–18.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48302, USA

    Charles A. Schiffer

Authors
  1. Charles A. Schiffer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles A. Schiffer .

Editor information

Editors and Affiliations

  1. Cleveland Clinic Foundation, Euclid Ave. 9500, Cleveland, 44195, Ohio, USA

    Anjali S. Advani

  2. School of Medicine, University Hospitals of Cleveland, Euclid Avenue 11100, Cleveland, 44106, Ohio, USA

    Hillard M. Lazarus

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Schiffer, C.A. (2011). A Perspective on the Treatment of Acute Lymphoblastic Leukemia in Adults. In: Advani, A., Lazarus, H. (eds) Adult Acute Lymphocytic Leukemia. Contemporary Hematology. Humana Press. https://doi.org/10.1007/978-1-60761-707-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-707-5_1

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-706-8

  • Online ISBN: 978-1-60761-707-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation